Laden…
3-[2-(dimethylamino)ethyl]-1H-indol-4-ol
Psilocin is a psychoactive tryptamine that primarily acts as an active metabolite of psilocybin. It mainly binds to serotonin receptors, particularly 5-HT2A, thereby inducing psychedelic effects. The substance is being investigated in research for consciousness alteration and potential therapeutic applications. Risks primarily involve psychological stress and the possibility of unpleasant experiences.
Class
Tryptamine
Pharmacological context
Mechanism
Psilocin (4-Hydroxy-N,N-Dimethyltryptamin) ist der aktive Metabolit von...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Receptor Targets
Mechanism of Action
Designations
IUPAC: Psilocin
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology is partially translated. Some details are still being expanded.
Psilocin (4-Hydroxy-N,N-Dimethyltryptamin) ist der aktive Metabolit von Psilocybin und wirkt direkt (ohne Prodrug-Umwandlung) als partieller Agonist am 5-HT2A-Rezeptor – der primäre psychedelische mechanism of action. Zusätzlich agonisiert Psilocin 5-HT2C-, 5-HT1A-, 5-HT1B-, 5-HT1D-, 5-HT6- und 5-HT7-Rezeptoren. Der SERT ist ein schwacher Substrat (Reuptake-Hemmung), aber nicht signifikant im Vergleich zu DMT. Aufgrund der fehlenden Prodrug-Konversions-Stufe im Gastrointestinaltrakt hat Psilocin schnelleren Wirkungseintritt als Psilocybin und ist etwas potenter auf Gewichtsbasis.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 5–10 mg
Total duration 4–6 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 1–2 mg |
| Reported | 5–10 mg |
| Strong | 15–30 mg |
Oral
Onset
20–40 minutes
Peak
1–2 hours
Total duration
4–6 hours
After effects
1–3 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.